SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Deli Solar (USA), Inc. (CIK 0000717588) — Jul 6, 2005

Deli Solar (USA), Inc. (CIK 0000717588)
Date: July 6, 2005 · CIK: 0000717588 · Accession: 0001010549-05-000487

AI Filing Summary & Sentiment

Referenced dates: May 26, 2005

Date
July 6, 2005
Author
/s/ Kevin Halter, Jr.
Form
CORRESP
Company
Deli Solar (USA), Inc. (CIK 0000717588)

Letter

MEDITECH PHARMACEUTICALS 2591 Dallas Parkway - Suite 102 - Frisco, TX 75034 972-963-0000 July 6, 2005 Sasha Parikh Securities and Exchange Commission Mail Stop 03-09 Washington, DC 20549

Dear Ms. Parikh:

Reference is made to File No. 0-12561 and your letter dated May 26, 2005.

We acknowledge that:

1. The company is responsible for the adequacy and accuracy of the disclosure in the filings; 2. Staff comments or changes to disclosure in response to staff comments in the filings reviewed by the staff do not foreclose the Commission from taking any action with respect to the filing; and 3. The company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Sincerely,
/s/ Kevin Halter, Jr.

Show Raw Text
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>

                            MEDITECH PHARMACEUTICALS
               2591 Dallas Parkway - Suite 102 - Frisco, TX 75034
                                  972-963-0000

July 6, 2005

Sasha Parikh
Securities and Exchange Commission
Mail Stop 03-09
Washington, DC 20549

Dear Ms. Parikh:

Reference is made to File No. 0-12561 and your letter dated May 26, 2005.

We acknowledge that:

1.       The  company  is  responsible  for the  adequacy  and  accuracy  of the
         disclosure in the filings;
2.       Staff  comments or changes to disclosure in response to staff  comments
         in the filings  reviewed by the staff do not foreclose  the  Commission
         from taking any action with respect to the filing; and
3.       The  company  may  not  assert  staff  comments  as a  defense  in  any
         proceeding  initiated by the Commission or any person under the federal
         securities laws of the United States.

Sincerely,

/s/ Kevin Halter, Jr.

Kevin Halter, Jr.

</TEXT>
</DOCUMENT>